Dr. Langdon Miller, MD

NPI: 1265944003
Total Payments
$674,815
2024 Payments
$9,688
Companies
5
Transactions
10

Payment Breakdown by Category

Consulting$674,540 (100.0%)
Food & Beverage$275.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $674,540 8 100.0%
Food and Beverage $275.00 2 0.0%

Top Paying Companies

Company Total Records Latest Year
AI Therapeutics, Inc. $477,613 5 $0 (2022)
LAM Therapeutics, Inc. $173,615 1 $0 (2017)
OrphAI Therapeutics Inc. $23,313 2 $0 (2024)
Seagen Inc. $150.00 1 $0 (2022)
AstraZeneca Pharmaceuticals LP $125.00 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $9,688 1 OrphAI Therapeutics Inc. ($9,688)
2023 $13,750 2 OrphAI Therapeutics Inc. ($13,625)
2022 $11,588 2 AI Therapeutics, Inc. ($11,438)
2021 $196,375 1 AI Therapeutics, Inc. ($196,375)
2020 $49,563 1 AI Therapeutics, Inc. ($49,563)
2019 $175,538 1 AI Therapeutics, Inc. ($175,538)
2018 $44,700 1 AI Therapeutics, Inc. ($44,700)
2017 $173,615 1 LAM Therapeutics, Inc. ($173,615)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/23/2024 OrphAI Therapeutics Inc. Consulting Fee Cash or cash equivalent $9,687.50 General
11/07/2023 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Oncology
03/24/2023 OrphAI Therapeutics Inc. Consulting Fee Cash or cash equivalent $13,625.00 General
12/01/2022 Seagen Inc. TUKYSA (Drug) Food and Beverage In-kind items and services $150.00 General
Category: Oncology
01/17/2022 AI Therapeutics, Inc. Consulting Fee Cash or cash equivalent $11,437.50 General
12/01/2021 AI Therapeutics, Inc. Consulting Fee Cash or cash equivalent $196,375.00 General
01/22/2020 AI Therapeutics, Inc. Consulting Fee Cash or cash equivalent $49,562.50 General
10/12/2019 AI Therapeutics, Inc. Consulting Fee Cash or cash equivalent $175,537.50 General
01/18/2018 AI Therapeutics, Inc. Consulting Fee Cash or cash equivalent $44,700.00 General
01/19/2017 LAM Therapeutics, Inc. Consulting Fee Cash or cash equivalent $173,615.45 General

About Dr. Langdon Miller, MD

Dr. Langdon Miller, MD is a Hematology & Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1265944003.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Langdon Miller, MD has received a total of $674,815 in payments from pharmaceutical and medical device companies, with $9,688 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($674,540).

Practice Information

  • Specialty Hematology & Oncology
  • Location Seattle, WA
  • Active Since 11/02/2017
  • Last Updated 11/02/2017
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1265944003

Products in Payments

  • TUKYSA (Drug) $150.00
  • ENHERTU (Biological) $125.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Seattle